Shawn M. Heidel

593 total citations
11 papers, 428 citations indexed

About

Shawn M. Heidel is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Shawn M. Heidel has authored 11 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Shawn M. Heidel's work include Biosimilars and Bioanalytical Methods (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Carcinogens and Genotoxicity Assessment (2 papers). Shawn M. Heidel is often cited by papers focused on Biosimilars and Bioanalytical Methods (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Carcinogens and Genotoxicity Assessment (2 papers). Shawn M. Heidel collaborates with scholars based in United States, Germany and Netherlands. Shawn M. Heidel's co-authors include Jeffrey C. Hanson, Daniel G. Rudmann, James T. Alston, Colin R. Jefcoate, Charles J. Czuprynski, Jeroen Buters, Frank J. Gonzalez, Wan Mohaiza Dashwood, William M. Baird and Michele Campaigne Larsen and has published in prestigious journals such as Molecular Pharmacology, Regulatory Toxicology and Pharmacology and Toxicologic Pathology.

In The Last Decade

Shawn M. Heidel

11 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shawn M. Heidel United States	9	185	102	92	68	53	11	428
Annalisa Zunino Italy	14	311 1.7×	211 2.1×	94 1.0×	219 3.2×	59 1.1×	27	646
Christin E. Petre United States	7	283 1.5×	93 0.9×	30 0.3×	222 3.3×	124 2.3×	7	631
Shuxia Yang China	15	167 0.9×	50 0.5×	160 1.7×	64 0.9×	5 0.1×	34	546
C. Brindley United Kingdom	11	322 1.7×	65 0.6×	150 1.6×	79 1.2×	11 0.2×	14	523
Joshua Prey United States	13	242 1.3×	43 0.4×	39 0.4×	113 1.7×	13 0.2×	22	550
Fatemeh Rezaei‐Tazangi Iran	12	277 1.5×	129 1.3×	72 0.8×	121 1.8×	25 0.5×	55	572
Guoqing Li China	13	271 1.5×	138 1.4×	97 1.1×	68 1.0×	11 0.2×	20	555
Yinci Zhang China	15	252 1.4×	98 1.0×	36 0.4×	84 1.2×	10 0.2×	23	458

Countries citing papers authored by Shawn M. Heidel

Since Specialization

Citations

This map shows the geographic impact of Shawn M. Heidel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shawn M. Heidel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shawn M. Heidel more than expected).

Fields of papers citing papers by Shawn M. Heidel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shawn M. Heidel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shawn M. Heidel. The network helps show where Shawn M. Heidel may publish in the future.

Co-authorship network of co-authors of Shawn M. Heidel

This figure shows the co-authorship network connecting the top 25 collaborators of Shawn M. Heidel. A scholar is included among the top collaborators of Shawn M. Heidel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shawn M. Heidel. Shawn M. Heidel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Sewell, Fiona, Kathryn Chapman, Jessica A. Couch, et al.. (2017). Challenges and opportunities for the future of monoclonal antibody development: Improving safety assessment and reducing animal use. mAbs. 9(5). 742–755. 20 indexed citations

Rudmann, Daniel G., James T. Alston, Jeffrey C. Hanson, & Shawn M. Heidel. (2013). High Molecular Weight Polyethylene Glycol Cellular Distribution and PEG-associated Cytoplasmic Vacuolation Is Molecular Weight Dependent and Does Not Require Conjugation to Proteins. Toxicologic Pathology. 41(7). 970–983. 142 indexed citations

Ponce, Rafael, Thomas Gelzleichter, Helen G. Haggerty, et al.. (2013). Immunomodulation and lymphoma in humans. Journal of Immunotoxicology. 11(1). 1–12. 17 indexed citations

Vahle, John L., Gregory L. Finch, Shawn M. Heidel, et al.. (2010). Carcinogenicity Assessments of Biotechnology-Derived Pharmaceuticals. Toxicologic Pathology. 38(4). 522–553. 16 indexed citations

Nakazawa, Takahiro, Shigeru Hisada, Tadashi Inoue, et al.. (2008). Safety assessment of biopharmaceuticals: Japanese perspective on ICH S6 guideline maintenance. The Journal of Toxicological Sciences. 33(3). 277–282. 7 indexed citations

Vick, Andrew, et al.. (2007). A 6-Month Inhalation Study to Characterize the Toxicity, Pharmacokinetics, and Pharmacodynamics of Human Insulin Inhalation Powder (HIIP) in Beagle Dogs. PubMed. 20(2). 112–126. 9 indexed citations

Clarke, Janet, Christopher Hurst, Pauline L. Martin, et al.. (2007). Duration of chronic toxicity studies for biotechnology-derived pharmaceuticals: Is 6 months still appropriate?. Regulatory Toxicology and Pharmacology. 50(1). 2–22. 33 indexed citations

Heidel, Shawn M., P S MacWilliams, William M. Baird, et al.. (2000). Cytochrome P4501B1 mediates induction of bone marrow cytotoxicity and preleukemia cells in mice treated with 7,12-dimethylbenz[a]anthracene.. PubMed. 60(13). 3454–60. 88 indexed citations

Heidel, Shawn M., et al.. (1999). Bone Marrow Stromal Cell Cytochrome P4501B1 Is Required for Pre-B Cell Apoptosis Induced by 7,12-Dimethylbenz[a]anthracene. Molecular Pharmacology. 56(6). 1317–1323. 45 indexed citations

10.

Heidel, Shawn M., Charles J. Czuprynski, & Colin R. Jefcoate. (1998). Bone Marrow Stromal Cells Constitutively Express High Levels of Cytochrome P4501B1 that Metabolize 7,12-Dimethylbenz[a]anthracene. Molecular Pharmacology. 54(6). 1000–1006. 45 indexed citations

11.

Hsieh, Jer Tsong, Mitchell F. Denning, Shawn M. Heidel, & Ajit Kumar Verma. (1990). Expression of human chromosome 2 ornithine decarboxylase gene in ornithine decarboxylase-deficient Chinese hamster ovary cells.. PubMed. 50(8). 2239–44. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact